These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 9207819

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Rabeprazole versus ranitidine for the treatment of erosive gastroesophageal reflux disease: a double-blind, randomized clinical trial. Raberprazole Study Group.
    Farley A, Wruble LD, Humphries TJ.
    Am J Gastroenterol; 2000 Aug; 95(8):1894-9. PubMed ID: 10950032
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. High- versus standard-dose ranitidine for control of heartburn in poorly responsive acid reflux disease: a prospective, controlled trial.
    Kahrilas PJ, Fennerty MB, Joelsson B.
    Am J Gastroenterol; 1999 Jan; 94(1):92-7. PubMed ID: 9934737
    [Abstract] [Full Text] [Related]

  • 8. On-demand treatment of acute heartburn with the antacid hydrotalcite compared with famotidine and placebo: randomized double-blind cross-over study.
    Holtmeier W, Holtmann G, Caspary WF, Weingärtner U.
    J Clin Gastroenterol; 2007 Jul; 41(6):564-70. PubMed ID: 17577112
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Metoclopramide in gastroesophageal reflux disease: rationale for its use and results of a double-blind trial.
    McCallum RW, Fink SM, Winnan GR, Avella J, Callachan C.
    Am J Gastroenterol; 1984 Mar; 79(3):165-72. PubMed ID: 6367434
    [Abstract] [Full Text] [Related]

  • 15. Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice.
    Venables TL, Newland RD, Patel AC, Hole J, Wilcock C, Turbitt ML.
    Scand J Gastroenterol; 1997 Oct; 32(10):965-73. PubMed ID: 9361167
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The effect of over-the-counter ranitidine 75 mg on night-time heartburn in patients with erosive oesophagitis on daily proton pump inhibitor maintenance therapy.
    Vakil N, Guda N, Partington S.
    Aliment Pharmacol Ther; 2006 Mar 01; 23(5):649-53. PubMed ID: 16480404
    [Abstract] [Full Text] [Related]

  • 18. Cimetidine in the treatment of symptomatic gastroesophageal reflux: a double blind controlled trial.
    Behar J, Brand DL, Brown FC, Castell DO, Cohen S, Crossley RJ, Pope CE, Winans CS.
    Gastroenterology; 1978 Feb 01; 74(2 Pt 2):441-8. PubMed ID: 340333
    [Abstract] [Full Text] [Related]

  • 19. Nizatidine versus placebo in gastroesophageal reflux disease: a 12-week, multicenter, randomized, double-blind study.
    Cloud ML, Offen WW, Robinson M.
    Am J Gastroenterol; 1991 Dec 01; 86(12):1735-42. PubMed ID: 1962618
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.